Kuo‐Chin Chang

1.9k citations

82 papers · 1.4k indexed · h-index 24

Co-authors: Tsung‐Hui Hu Po‐Lin Tseng Chien‐Hung Chen Sheng‐Nan Lu Ming‐Chao Tsai Yi‐Hao Yen Jing‐Houng Wang Chao‐Hung Hung
Topics: Liver Disease Diagnosis and Treatment (62 papers)Hepatitis C virus research (54 papers)Hepatitis B Virus Studies (47 papers)
Cited by: Hepatology Epidemiology Gastroenterology
Journals: PLoS ONE Scientific Reports Journal of Clinical Microbiology
Partner nations: Taiwan United States China

In The Last Decade

Kuo‐Chin Chang

80 papers receiving 1.4k citations

Peers

Countries citing papers authored by Kuo‐Chin Chang

Since Specialization

Citations

This map shows the geographic impact of Kuo‐Chin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Chin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Chin Chang more than expected).

Fields of papers citing papers by Kuo‐Chin Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Chin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Chin Chang. The network helps show where Kuo‐Chin Chang may publish in the future.

Co-authorship network of co-authors of Kuo‐Chin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Chin Chang. A scholar is included among the top collaborators of Kuo‐Chin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Chin Chang. Kuo‐Chin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A long term bone and renal safety of TAF treatment on renal transplant recipients 2025 ·Biomedical Journal ·Desmond Y. H. Yap,Cheng‐Kun Wu,Colin Tang,Kuo‐Chin Chang,Wen‐Chin Lee,David Tak Wai Lui,(unknown),Tsung‐Hui Hu,Tak Mao Chan	0
2	Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation 2023 ·Journal of Infection and Public Health ·(unknown),Tsung‐Hui Hu,Yeh‐Pin Chou,Yuan‐Hung Kuo,Ming‐Chao Tsai,Kuo‐Chin Chang,Yi‐Hao Yen,Po‐Lin Tseng	1
3	Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan 2020 ·Alimentary Pharmacology & Therapeutics ·Tsung‐Hui Hu,Sherry Yueh‐Hsia Chiu,Po‐Lin Tseng,Chien‐Hung Chen,Sheng‐Nan Lu,Jing‐Houng Wang,Chao‐Hung Hung,Kwong‐Ming Kee,Ming‐Tsung Lin,Kuo‐Chin Chang,Meng‐Chih Lin,Rong‐Nan Chien	14
4	The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection 2019 ·Gastroenterology Research and Practice ·(unknown),Yi‐Hao Yen,Pao‐Yuan Huang,(unknown),Chih‐Che Lin,(unknown),(unknown),(unknown),Kuo‐Chin Chang,Cheng‐Kun Wu,Tsung‐Hui Hu,Ming‐Chao Tsai	3
5	Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients 2018 ·Digestive and Liver Disease ·Yi‐Hao Yen,Fang‐Ying Kuo,Kwong‐Ming Kee,Kuo‐Chin Chang,Ming‐Chao Tsai,Tsung‐Hui Hu,Sheng‐Nan Lu,Jing‐Houng Wang,Chao‐Hung Hung,Chien‐Hung Chen	2
6	Did AFP‐L3 save ultrasonography in community screening? 2018 ·The Kaohsiung Journal of Medical Sciences ·Chih‐Wei Yen,Yuan‐Hung Kuo,Jing‐Houng Wang,Kuo‐Chin Chang,Kwong‐Ming Kee,(unknown),Yi Chen,Lin‐San Tsai,Shu‐Chuan Chen,Chao‐Hung Hung,Sheng‐Nan Lu	5
7	The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients 2017 ·Liver International ·Yi‐Hao Yen,Ming‐Tsung Lin,Fang‐Ying Kuo,Kuo‐Chin Chang,Ming‐Chao Tsai,Po‐Lin Tseng,Cheng‐Kun Wu,(unknown),Tsung‐Hui Hu,Sheng‐Nan Lu,Jing‐Houng Wang,Chao‐Hung Hung,Chien‐Hung Chen	14
8	Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy 2017 ·Medicine ·(unknown),Tsung‐Hui Hu,Kuo‐Chin Chang,Po‐Lin Tseng,Sheng‐Nan Lu,Chien‐Hung Chen,Jing‐Houng Wang,Chuan–Mo Lee,Ming‐Chao Tsai,Ming‐Tsung Lin,Yi‐Hao Yen,Chao‐Hung Hung,Chung-Lung Cho,Cheng‐Kun Wu	9
9	The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice 2017 ·Journal of the Formosan Medical Association ·Yi‐Hao Yen,Jung‐Fu Chen,Cheng‐Kun Wu,Ming‐Tsung Lin,Kuo‐Chin Chang,Po‐Lin Tseng,Ming‐Chao Tsai,(unknown),Tsung‐Hui Hu	10
10	Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease 2017 ·Journal of the Formosan Medical Association ·Yi‐Hao Yen,Kuo‐Chin Chang,Ming‐Chao Tsai,Po‐Lin Tseng,Ming‐Tsung Lin,Cheng‐Kun Wu,(unknown),Tsung‐Hui Hu,Jing‐Houng Wang,Chien‐Hung Chen	17
11	Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy 2016 ·Journal of Antimicrobial Chemotherapy ·Cheng‐Kun Wu,Kuo‐Chin Chang,Chao‐Hung Hung,Po‐Lin Tseng,Sheng‐Nan Lu,Chien‐Hung Chen,Jing‐Houng Wang,Chuan–Mo Lee,Ming‐Chao Tsai,Ming‐Tsung Lin,Yi‐Hao Yen,Tsung‐Hui Hu	20
12	Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community 2016 ·PLoS ONE ·Yuan‐Hung Kuo,Ming‐Chao Tsai,Kwong‐Ming Kee,Kuo‐Chin Chang,Jing‐Houng Wang,(unknown),(unknown),Sheng‐Nan Lu	7
13	Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care 2015 ·PLoS ONE ·Yuan‐Hung Kuo,(unknown),Jing‐Houng Wang,Kuo‐Chin Chang,Kwong‐Ming Kee,Ming‐Chao Tsai,(unknown),(unknown),Lin‐San Tsai,Shu‐Chuan Chen,Sheng‐Nan Lu	10
14	Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience 2015 ·Clinical Microbiology and Infection ·Ming‐Chao Tsai,Chia‐Hsiang Chen,Po‐Lin Tseng,Chih‐Hsien Hung,King‐Wah Chiu,J.-H. Wang,Sheng‐Nan Lu,C.-M. Lee,Kuo‐Chin Chang,Yi‐Hao Yen,Ming‐Tsung Lin,Yeh‐Pin Chou,Tsung‐Hui Hu	50
15	Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice 2014 ·Biomedical Journal ·Wei‐Chen Tai,Ming‐Tsung Lin,Tsung‐Hui Hu,(unknown),Kuo‐Chin Chang,King‐Wah Chiu,Shue‐Shian Chiou,Seng‐Kee Chuah,Chih‐Ming Liang,Chung‐Mou Kuo,Keng‐Liang Wu	23
16	A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice 2011 ·Journal of Antimicrobial Chemotherapy ·Ming‐Chao Tsai,C.-M. Lee,King‐Wah Chiu,Chien‐Hui Hung,Wei‐Chen Tung,Chia‐Hsiang Chen,Po‐Lin Tseng,Kuo‐Chin Chang,J.-H. Wang,Sheng‐Nan Lu,Yi‐Hao Yen,Tsung‐Hui Hu	25
17	Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies 2010 ·The American Journal of Gastroenterology ·Hung‐Da Tung,Jing‐Houng Wang,Po‐Lin Tseng,Chao‐Hung Hung,Kwong‐Ming Kee,Chien‐Hung Chen,Kuo‐Chin Chang,Chuan–Mo Lee,Chi‐Sin Changchien,(unknown),Sheng‐Nan Lu	41
18	Liver Tuberculosis in Southern Taiwan: 15-years Clinical Experience 2008 ·Wei‐Chen Tai,(unknown),(unknown),Seng-Kee Chuah,Chao‐Cheng Huang,Tsung‐Hui Hu,(unknown),(unknown),Kuo‐Chin Chang,Chi‐Sin Changchien	11
19	Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan 2006 ·World Journal of Gastroenterology ·Kuo‐Chin Chang,Seng-Kee Chuah,Chi‐Sin Changchien,Tung‐Lung Tsai,Sheng‐Nan Lu,Yi‐Chun Chiu,Yaw‐Sen Chen,Chih‐Chi Wang,Jui‐Wei Lin,Chuan–Mo Lee,Tsung‐Hui Hu	146
20	Clinical Analysis of the Efficacy in Lipase/Amylase Ratio for Acute Pancreatitis 2005 ·Kuo‐Chin Chang,Chi‐Sin Changchien,(unknown),Yi‐Chun Chiu,Seng-Kee Chuah,King‐Wah Chiu,Chung‐Huang Kuo	7

About Kuo‐Chin Chang

Kuo‐Chin Chang is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 82 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (62 papers), Hepatitis C virus research (54 papers) and Hepatitis B Virus Studies (47 papers). The work is most often cited by research in Hepatology (877 citations), Epidemiology (947 citations) and Gastroenterology (74 citations). Kuo‐Chin Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Tsung‐Hui Hu, Po‐Lin Tseng, Chien‐Hung Chen, Sheng‐Nan Lu, Ming‐Chao Tsai, Yi‐Hao Yen, Jing‐Houng Wang, Chao‐Hung Hung, Kwong‐Ming Kee and Ming‐Tsung Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact